SCOPUS 정보 검색 플랫폼

Volumn 3, Issue 12, 2012, Pages 1500-1504

Synthesis and biological evaluation of 4-chlorocolchicine derivatives as potent anticancer agents with broad effective dosage ranges

(11) Nishiyama, Hiroyuki a,b Ono, Masahiro a Sugimoto, Takuya a Sasai, Toshio a Asakawa, Naoyuki a Yaegashi, Takashi a Nagaoka, Masato a Matsuzaki, Takeshi a Kogure, Noriyuki b Kitajima, Mariko b Takayama, Hiromitsu b

a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH (Japan)

b CHIBA UNIVERSITY (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 CHLOROCOLCHICINE DERIVATIVE; ANTINEOPLASTIC AGENT; BENZAMIDE; COLCHICINE DERIVATIVE; CYCLOHEXANECARBOXAMIDE; GLORIOSAMINE A; ISOVALERAMIDE; UNCLASSIFIED DRUG;

ACYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; CHEMICAL INTERACTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYDROGEN BOND; HYDROPHOBICITY; IN VITRO STUDY; LARYNX CARCINOMA; MOLECULAR DOCKING; MOUSE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL;

MUS;

EID: 84870022543 PISSN: 20402503 EISSN: 20402511 Source Type: Journal
DOI: 10.1039/c2md20250f Document Type: Article

Times cited : (10)

References (26)

1
- 4544286643
- T. Graening H.-G. Schmaltz Angew. Chem., Int. Ed. 2004 43 3230 3256
- (2004) Angew. Chem., Int. Ed. , vol.43 , pp. 3230-3256
- Graening, T.¹ Schmaltz, H.-G.²

2
- 37249020371
- B. Bhattacharyya D. Panda S. Gupta M. Banerjee Med. Res. Rev. 2008 28 155 183
- (2008) Med. Res. Rev. , vol.28 , pp. 155-183
- Bhattacharyya, B.¹ Panda, D.² Gupta, S.³ Banerjee, M.⁴

3
- 20044379560
- F. Q. Alali T. El-Elimat C. Li A. Qandil A. Alkofahi K. Tawaha J. P. Burgess Y. Nakanishi D. J. Kroll H. A. Navarro J. O. Falkinham, III M. C. Wani N. H. Oberlies J. Nat. Prod. 2005 68 173 178
- (2005) J. Nat. Prod. , vol.68 , pp. 173-178
- Alali, F.Q.¹ El-Elimat, T.² Li, C.³ Qandil, A.⁴ Alkofahi, A.⁵ Tawaha, K.⁶ Burgess, J.P.⁷ Nakanishi, Y.⁸ Kroll, D.J.⁹ Navarro, H.A.¹⁰ Falkinham Iii, J.O.¹¹ Wani, M.C.¹² Oberlies, N.H.¹³

4
- 0017112021
- J. T. Fitzgerald Biochem. Pharmacol. 1976 25 1383 1387
- (1976) Biochem. Pharmacol. , vol.25 , pp. 1383-1387
- Fitzgerald, J.T.¹

5
- 0022202415
- P. Kerekes N. P. Sharma A. Brossi F. C. Chignell R. F. Quinn J. Med. Chem. 1985 28 1204 1208
- (1985) J. Med. Chem. , vol.28 , pp. 1204-1208
- Kerekes, P.¹ Sharma, N.P.² Brossi, A.³ Chignell, F.C.⁴ Quinn, R.F.⁵

6
- 0019426065
- M. Rosner H.-G. Caprano E. A. Jacobson L. Atwell A. Brossi J. Med. Chem. 1981 24 257 261
- (1981) J. Med. Chem. , vol.24 , pp. 257-261
- Rosner, M.¹ Caprano, H.-G.² Jacobson, E.A.³ Atwell, L.⁴ Brossi, A.⁵

7
- 29244440370
- S.-H. Lee S.-K. Park J.-M. Kim M.-H. Kim K.-H. Kim K.-W. Chun K.-H. Cho J.-Y. Youn S. K. Namgoong Arch. Pharm. (Weinheim, Ger.) 2005 338 582 589
- (2005) Arch. Pharm. (Weinheim, Ger.) , vol.338 , pp. 582-589
- Lee, S.-H.¹ Park, S.-K.² Kim, J.-M.³ Kim, M.-H.⁴ Kim, K.-H.⁵ Chun, K.-W.⁶ Cho, K.-H.⁷ Youn, J.-Y.⁸ Namgoong, S.K.⁹

8
- 0020067747
- M. J. Andreu N. S. Timasheff Biochemistry 1982 21 534 543
- (1982) Biochemistry , vol.21 , pp. 534-543
- Andreu, M.J.¹ Timasheff, N.S.²

9
- 0030660614
- C. Dumortier Q. Yan S. Bane Y. Engelborghs Biochem. J. 1997 327 685 688
- (1997) Biochem. J. , vol.327 , pp. 685-688
- Dumortier, C.¹ Yan, Q.² Bane, S.³ Engelborghs, Y.⁴

10
- 33744477942
- K. Nakagawa-Goto M. K. Jung E. Hamel C.-C. Wu F. K. Bastow A. Brossi S. Ohta K.-H. Lee Heterocycles 2005 65 541 551
- (2005) Heterocycles , vol.65 , pp. 541-551
- Nakagawa-Goto, K.¹ Jung, M.K.² Hamel, E.³ Wu, C.-C.⁴ Bastow, F.K.⁵ Brossi, A.⁶ Ohta, S.⁷ Lee, K.-H.⁸

11
- 9644302431
- K. Nakagawa-Goto X. C. Chen E. Hamel C.-C. Wu F. K. Bastow A. Brossi K.-H. Lee Bioorg. Med. Chem. 2005 15 235 238
- (2005) Bioorg. Med. Chem. , vol.15 , pp. 235-238
- Nakagawa-Goto, K.¹ Chen, X.C.² Hamel, E.³ Wu, C.-C.⁴ Bastow, F.K.⁵ Brossi, A.⁶ Lee, K.-H.⁷

12
- 10844268815
- D. J. Bagnato L. A. Eilers A. R. Horton B. C. Grissom J. Org. Chem. 2004 69 8987 8996
- (2004) J. Org. Chem. , vol.69 , pp. 8987-8996
- Bagnato, D.J.¹ Eilers, L.A.² Horton, A.R.³ Grissom, B.C.⁴

13
- 14644386838
- L. Das B. A. Datta S. Gupta A. Poddar S. Sengupta E. M. Janik B. Bhattacharyya Biochemistry 2005 44 3249 3258
- (2005) Biochemistry , vol.44 , pp. 3249-3258
- Das, L.¹ Datta, B.A.² Gupta, S.³ Poddar, A.⁴ Sengupta, S.⁵ Janik, E.M.⁶ Bhattacharyya, B.⁷

14
- 33645848477
- M. Cifuentes B. Schilling R. Ravindra J. Winter E. Janik Bioorg. Med. Chem. Lett. 2006 16 2761 2764
- (2006) Bioorg. Med. Chem. Lett. , vol.16 , pp. 2761-2764
- Cifuentes, M.¹ Schilling, B.² Ravindra, R.³ Winter, J.⁴ Janik, E.⁵

15
- 77954212976
- B. Yang Z. C. Zhu H. V. Goodson M. J. Miller Bioorg. Med. Chem. Lett. 2010 20 3831 3833
- (2010) Bioorg. Med. Chem. Lett. , vol.20 , pp. 3831-3833
- Yang, B.¹ Zhu, Z.C.² Goodson, H.V.³ Miller, M.J.⁴

16
- 0013900491
- I. B. Boruchow Cancer 1966 19 541 543
- (1966) Cancer , vol.19 , pp. 541-543
- Boruchow, I.B.¹

17
- 11444252497
- J. Zhou P. Giannakakou Curr. Med. Chem.: Anti-Cancer Agents 2005 5 65 71
- (2005) Curr. Med. Chem.: Anti-Cancer Agents , vol.5 , pp. 65-71
- Zhou, J.¹ Giannakakou, P.²

18
- 0024448750
- S. Mendis Postgrad. Med. J. 1989 65 752 755
- (1989) Postgrad. Med. J. , vol.65 , pp. 752-755
- Mendis, S.¹

19
- 77955877747
- I. Mikaelian A. Buness M.-C. de Vera-Mudry C. Kanwal D. Coluccio E. Rasmussen H. W. Char V. Carvajal H. Hilton J. Funk J.-C. Hoflack M. Fielden F. Herting M. Dunn L. Suter-Dick Toxicol. Sci. 2010 117 144 151
- (2010) Toxicol. Sci. , vol.117 , pp. 144-151
- Mikaelian, I.¹ Buness, A.² De Vera-Mudry, M.-C.³ Kanwal, C.⁴ Coluccio, D.⁵ Rasmussen, E.⁶ Char, H.W.⁷ Carvajal, V.⁸ Hilton, H.⁹ Funk, J.¹⁰ Hoflack, J.-C.¹¹ Fielden, M.¹² Herting, F.¹³ Dunn, M.¹⁴ Suter-Dick, L.¹⁵

20
- 36849066221
- M. Kitajima A. Tanaka N. Kogure H. Takayama Tetrahedron Lett. 2008 49 257 260
- (2008) Tetrahedron Lett. , vol.49 , pp. 257-260
- Kitajima, M.¹ Tanaka, A.² Kogure, N.³ Takayama, H.⁴

21
- 79956105142
- Compound 26 that showed the most potent activity in vitro was unsuitable for evaluation in vivo because of its low solubility for use in intravenous injections The maximum dose (MD) was defined as the maximum single dose that induced less than 20% weight loss when the derivative was intravenously administered to a mouse on day 1 and 5
- N. Yasobu M. Kitajima N. Kogure Y. Shishido T. Matsuzaki M. Nagaoka H. Takayama ACS Med. Chem. Lett. 2011 2 348 352
- (2011) ACS Med. Chem. Lett. , vol.2 , pp. 348-352
- Yasobu, N.¹ Kitajima, M.² Kogure, N.³ Shishido, Y.⁴ Matsuzaki, T.⁵ Nagaoka, M.⁶ Takayama, H.⁷

22
- 77749315417
- For Slog P, see
- M. J. Waring Expert Opin. Drug Discovery 2010 5 235 248
- (2010) Expert Opin. Drug Discovery , vol.5 , pp. 235-248
- Waring, M.J.¹

23
- 0001509942
- S. A. Wildman G. M. Crippen J. Chem. Inf. Comput. Sci. 1999 39 868 873
- (1999) J. Chem. Inf. Comput. Sci. , vol.39 , pp. 868-873
- Wildman, S.A.¹ Crippen, G.M.²

24
- 12144289254
- P. Angehrn S. Buchmann C. Funk E. Goetschi H. Gmuender P. Hebeisen D. Kostrewa H. Link T. Luebbers R. Masciadri J. Nielsen P. Reindl F. Ricklin A. Schmitt-Hoffmann F.-P. Theil J. Med. Chem. 2004 47 1487 1513
- (2004) J. Med. Chem. , vol.47 , pp. 1487-1513
- Angehrn, P.¹ Buchmann, S.² Funk, C.³ Goetschi, E.⁴ Gmuender, H.⁵ Hebeisen, P.⁶ Kostrewa, D.⁷ Link, H.⁸ Luebbers, T.⁹ Masciadri, R.¹⁰ Nielsen, J.¹¹ Reindl, P.¹² Ricklin, F.¹³ Schmitt-Hoffmann, A.¹⁴ Theil, F.-P.¹⁵

25
- 85077634689
- O. Mitsunobu Synthesis 1981 1 28
- (1981) Synthesis , pp. 1-28
- Mitsunobu, O.¹

26
- 0020601791
- A. Brossi P. N. Sharma L. Atwell A. E. Jacobson M. A. Iorio M. Molinari C. F. Chignell J. Med. Chem. 1983 26 1365 1369
- (1983) J. Med. Chem. , vol.26 , pp. 1365-1369
- Brossi, A.¹ Sharma, P.N.² Atwell, L.³ Jacobson, A.E.⁴ Iorio, M.A.⁵ Molinari, M.⁶ Chignell, C.F.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.